Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05229211
Other study ID # PID291237
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 1, 2022
Est. completion date December 30, 2025

Study information

Verified date June 2024
Source University of Oxford
Contact Peter Watkinson, MD.
Phone 01865231448
Email ccrg.research@ndcn.ox.ac.uk@ndcn.ox.ac.uk
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Atrial fibrillation (AF) is a heart problem that causes an irregular heartbeat. It can cause the heart to beat more rapidly and reduce the heart's ability to pump blood around the body efficiently, causing heart failure. It also increases the risk of blood clots forming inside the heart. These clots may then be pumped out of the heart, through the blood vessels, to other parts of the body. This can cause strokes if the clots spread to the brain. AF is a common problem outside an Intensive Care Unit (ICU), where treatment is based on good, evidence-based guidelines designed to reduce the risk of problems like heart failure or strokes. Around 10% of patients treated in ICU develop atrial fibrillation as a complication of their underlying illness. Some patients will recover their normal heart rhythm before leaving the ICU, often with the help of some medical treatments. It is not known whether these patients will get AF again after leaving the ICU, or when this is likely to happen. It is also unknown whether patients who avoid AF whilst on the ICU may still be at high risk of developing it after they leave. This study will identify patients on the ICU who have no previous record of atrial fibrillation. These patients will be monitored whilst on the ICU to identify those who develop AF. Those patients who develop new onset AF will be monitored on the ward after leaving the ICU to see which patients have AF at this point. The heart monitoring will be repeated once the patients leave hospital, again to identify whether they have atrial fibrillation. Some studies suggest that AF during critical illness causes a long-term risk of recurrent AF and AF associated complications such as heart failure, stroke, and death. To understand how to minimise these risks in intensive care patients, we need to know how which patients who develop atrial fibrillation whilst in an ICU go on to have recurrent atrial fibrillation in hospital and in the community. These patients may benefit from interventions to reduce long term adverse events such as anticoagulation to reduce stroke risk.


Description:

The study aims to determine whether it is feasible to screen patients to detect atrial fibrillation after treatment on an intensive care unit. Patients who develop new onset AF in ICU who have no history of atrial fibrillation prior to ICU admission will be included. These patients will be monitored for atrial fibrillation on the ward post ICU discharge (for 14 days or until hospital discharge), and then again at 3 months post hospital discharge (for 7 days), when they attend the routine post ICU follow up clinic. In the ICU, this study cohort of patients will be monitored continuously to detect atrial fibrillation. If atrial fibrillation is suspected, this will be confirmed by independent review of a 12-lead ECG. On the ward, post ICU discharge patients will be given a chest patch for continuous cardiac rhythm monitoring designed to detect arrhythmia, which they will wear for 7 days, before a second patch is used for a further 7 days or until hospital discharge, whichever is shortest in duration. Data relating to past medical history, history of illness requiring ICU admission, subsequent events post ICU discharge and complications post-hospital discharge including hospital readmissions will be collected via hospital records and by patient interview at the follow up clinic. Patients will attend the ICU follow up clinic at 3 months post hospital discharge. At this time, they will be provided with a new chest patch from the same manufacturer, which they will wear for 7 days. The primary aim will be to demonstrate the feasibility of monitoring patients for AF occurrence post ICU discharge using a wearable patch device. Secondary aims will be to identify the proportion of patients who develop NOAF (New onset atrial fibrillation) in ICU who go on to have AF post discharge, as well as documenting the stroke risk, mortality and length of hospital stay in this patient group. This study will guide the design of a larger study investigating AF occurrence and stroke risk in patients post ICU discharge. Exploratory objectives include to validate a newly designed AF detection algorithm. Objective 1: Validation of a new state-of-the-art machine learning algorithm against the manufactured-approved AF detection algorithm and three best-in-class algorithms. Objective 2: Identify subgroups of patients that are at increased risk of adverse outcomes of new onset atrial fibrillation in ICU compared to those who are not.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 30, 2025
Est. primary completion date December 30, 2025
Accepts healthy volunteers
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - Willing and able to give informed consent for participation in the study, or favourable consultee advice for adults lacking capacity - Male or Female, - aged 16 years or above. - Admitted to intensive care for >24 hours - New onset atrial fibrillation as confirmed by 12 lead ECG- Exclusion Criteria: - History of atrial fibrillation - Unable to undergo cardiac monitoring - Previously included in the study - Not anticipated by treating consultant to survive to ICU discharge (withdrawal or limitation of medical treatment at time of screening) - Contraindication to anticoagulation - Unable to wear the device for the prescribed monitoring period - Implanted neurostimulator, as this may disrupt the ECG recording

Study Design


Intervention

Device:
Cardiac monitoring
Continuous ECG monitoring via VitalConnect patch worn on the chest.

Locations

Country Name City State
United Kingdom Oxford University Hospitals Trust Oxford Oxfordshire

Sponsors (1)

Lead Sponsor Collaborator
University of Oxford

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Proportion of AF episodes detected compared to a. Validated CE marked algorithm b. Compared to 3 best-in-class algorithms 3 months post hospital discharge
Other Identify subgroups of patients that are at increased risk of adverse outcomes of new onset atrial fibrillation in ICU compared to those who are not. Perform subgroup analysis of results in both study groups, adverse outcomes defined as stroke, TIA, bleeding complications At completion of study at 3 months post hospital discharge.
Primary Proportion of eligible patients who are willing to participate in the study 3 months post hospital discharge
Primary Proportion of patients who are compliant with the study protocol 3 months post hospital discharge
Primary Proportion of patients lost to follow up 3 months post hospital discharge
Secondary Proportion of patients who are in AF post ICU discharge in hospital. 14 days post ICU hospital discharge
Secondary Proportion of patients who are in AF at 3 months post hospital discharge 3 months post hospital discharge
Secondary Proportion of patients who develop NOAF in ICU who develop stroke or TIA post ICU discharge 14 days post ICU discharge
Secondary Proportion of patients who develop NOAF in ICU who develop stroke or TIA post hospital discharge 3 months post hospital discharge
Secondary Difference in hospital length of stay in patients who develop atrial fibrillation after ICU discharge compared to patients who do not. To compare patients who develop NOAF in ICU and have recurrent AF in hospital with those who do not have recurrent AF in hospital Follow up patient appointment at 3 months post hospital discharge.
Secondary Difference in number of ICU readmissions in patients who develop atrial fibrillation after ICU discharge compared to those who do not. To compare patients who develop NOAF in ICU and have recurrent AF in hospital with those who do not have recurrent AF in hospital Follow up patient appointment at 3 months post hospital discharge.
Secondary Difference in mortality in patients who develop atrial fibrillation after ICU discharge compared to those who do not. To compare patients who develop NOAF in ICU and have recurrent AF in hospital and/or post hospital discharge with those who do not have recurrent AF. From ICU discharge to follow up patient appointment at 3 months post hospital discharge.
Secondary Proportion of patients who develop NOAF in ICU who develop bleeding complications post ICU discharge. Major and minor bleeding episodes as defined by the International Society on Thrombosis and Haemostasis Criteria. From ICU discharge to 14 days post ICU discharge
Secondary Proportion of patients who develop NOAF in ICU who develop bleeding complications post hospital discharge. Major and minor bleeding episodes as defined by the International Society on Thrombosis and Haemostasis Criteria. 3 months post hospital discharge
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Terminated NCT04115735 - His Bundle Recording From Subclavian Vein
Completed NCT04571385 - A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF) Phase 2
Completed NCT05366803 - Women's Health Initiative Silent Atrial Fibrillation Recording Study N/A
Completed NCT02864758 - Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
Recruiting NCT05442203 - Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease N/A
Completed NCT05599308 - Evaluation of Blood Pressure Monitor With AFib Screening Feature N/A
Completed NCT03790917 - Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
Enrolling by invitation NCT05890274 - Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO N/A
Recruiting NCT05266144 - Atrial Fibrillation Patients Treated With Catheter Ablation
Recruiting NCT05316870 - Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation N/A
Not yet recruiting NCT06023784 - The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Recruiting NCT04092985 - Smart Watch iECG for the Detection of Cardiac Arrhythmias
Completed NCT04087122 - Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures N/A
Completed NCT06283654 - Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
Recruiting NCT05416086 - iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed NCT04546763 - Study Watch AF Detection At Home
Completed NCT03761394 - Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke N/A